Evidence map›Paper›PMID 35011468›Full record

ReviewMolecules (Basel, Switzerland)2021

New Promising Therapeutic Avenues of Curcumin in Brain Diseases.

Tarek Benameur, Giulia Giacomucci, Maria Antonietta Panaro, Melania Ruggiero, Teresa Trotta, Vincenzo Monda, Ilaria Pizzolorusso, Dario Domenico Lofrumento, Chiara Porro, Giovanni Messina

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Tarek BenameurDepartment of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Giulia GiacomucciDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-8711-331X
Maria Antonietta PanaroBiotechnologies and Biopharmaceutics, Department of Biosciences, University of Bari, 70125 Bari, Italy.ORCID 0000-0001-5457-1069
Melania RuggieroBiotechnologies and Biopharmaceutics, Department of Biosciences, University of Bari, 70125 Bari, Italy.
Teresa TrottaDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0001-5693-6172
Vincenzo MondaDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0002-6083-5814
Ilaria PizzolorussoChild and Adolescent Neuropsychiatry Unit, Department of Mental Health, ASL Foggia, 71121 Foggia, Italy.
Dario Domenico LofrumentoDepartment of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, 73100 Lecce, Italy.ORCID 0000-0002-0106-3615
Chiara PorroDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0002-7526-6968
Giovanni MessinaDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0002-0011-867X
University of Foggia · ITUniversity of Bari Aldo Moro · ITKing Faisal University · SAUniversity of Florence · ITUniversity of Salento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin, the dietary polyphenol isolated from

Indexed as

AnimalsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicAntioxidantsBiomarkersBrain DiseasesCurcuminDiagnosis, DifferentialDisease ManagementDisease SusceptibilityHumansTreatment OutcomeAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicAntioxidantsBiomarkersCurcuminAlzheimer’s diseasesanti-inflammatorycurcuminepilepsyglioblastoma multiformemultiple sclerosisnatural flavonoidneurodegenerative diseasesneuroinflammationParkinson’s diseases

Identifiers

PMID35011468
PMCPMC8746812
OpenAlexW4205914457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.